Observe Medical ASA – Rights issue approved by the extraordinary general meeting
Reference is made to the stock exchange announcements published by Observe Medical ASA (the "Company") on 14 January 2022 regarding a proposed fully underwritten rights issue in the Company (the "Rights Issue"). The extraordinary general meeting of the Company has today, on 4 February 2022, approved the Rights Issue and the authorisation to the board of directors to issue the consideration shares in connection with the Company's contemplated acquisition of Biim Ultrasound AS. The minutes from the extraordinary general meeting are attached hereto. The full terms and conditions for the